TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07272720: Post-Market Clinical Follow-Up Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones - A Confirmatory Parallel-Group, Randomized Controlled Trial

Sponsor: Storz Medical AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 126 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07272720 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07272720 Rescue Dossier →